
    
      This is a multi-centre prospective, non-inferiority trial. Patients will be randomized to two
      treatment groups in a 1:1 ratio and will be stratified by:

        -  Age (<65 and ≥65 years old)

        -  Karnofsky Performance Status (≤70 and > 7050 or higher)

        -  Extent of the resection at surgery (biopsy only versus complete/near total and gross
           total or incomplete /partial resection)

      Randomization:

      Patients will be randomized to receive one of the two following treatments:

      Arm 1:

        -  Short Radiotherapy

        -  25 Gy/5 fractions

        -  1 week (5 fractions per week)

      Arm 2:

        -  Regular Radiotherapy

        -  40 Gy/15 fractions

        -  3 weeks (5 fractions per week)
    
  